← back to search

Valentin Dérangère

Centre Georges François Leclerc · FR
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, and Immunotherapy and Immune Responses.
h-index
36
citations
6,166
works
219
NIH funding
primary concept
Medicine
email

Recent publications

Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer.
2026cited by 0position: contributordoi
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells.
2022cited by 182position: contributordoi
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects.
2022cited by 11position: contributordoi
Follicular helper-T cells restore CD8<sup>+</sup>-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy.
2021cited by 93position: contributordoi
Deep learning for colon cancer histopathological images analysis.
2021cited by 73position: contributordoi
Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1.
2021cited by 22position: contributordoi
Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets JAK2/STAT3 Signaling, Migration and Invasion of Triple-Negative Breast Cancer Cells.
2021cited by 17position: contributordoi
Using a convolutional neural network for classification of squamous and non-squamous non-small cell lung cancer based on diagnostic histopathology HES images.
2021cited by 17position: contributordoi
New Artificial Intelligence Score and Immune Infiltrates as Prognostic Factors in Colorectal Cancer With Brain Metastases.
2021cited by 9position: contributordoi
TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer.
2021cited by 9position: contributordoi
Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and impact on patients.
2021cited by 9position: contributordoi
Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer.
2021cited by 6position: contributordoi
Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers?
2021cited by 2position: contributordoi
Using a Convolutional Neural Network for Classification of Squamous and Non-Squamous Non-Small Cell Lung Cancer Based on Diagnostic Histopathology HES Images
2021cited by 0position: contributordoi
Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients.
2020cited by 198position: contributordoi
Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction.
2020cited by 148position: contributordoi
Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study.
2020cited by 87position: contributordoi
Interplay between Liver X Receptor and Hypoxia Inducible Factor 1α Potentiates Interleukin-1β Production in Human Macrophages.
2020cited by 47position: contributordoi
Radiotherapy Scheme Effect on PD-L1 Expression for Locally Advanced Rectal Cancer.
2020cited by 19position: contributordoi
Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice.
2020cited by 15position: contributordoi
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.
2019cited by 177position: contributordoi
Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
2019cited by 119position: contributordoi
HSP70 is a negative regulator of NLRP3 inflammasome activation.
2019cited by 72position: contributordoi
Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance.
2019cited by 67position: contributordoi
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
2019cited by 7position: contributordoi
Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale.
2019cited by 6position: contributordoi
Hypotonic stress enhances colon cancer cell death induced by platinum derivatives and immunologically improves antitumor efficacy of intraperitoneal chemotherapy.
2019cited by 2position: contributordoi
IRF8-dependent molecular complexes control the Th9 transcriptional program
Nature Communications 2017cited by 62position: middledoi
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
Immunity 2012cited by 324position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

François Ghiringhelli · Peuplements végétaux et bioagresseurs en milieu tropical24 papers (2019–2026)Cédric Rébé · La Ligue Contre le Cancer9 papers (2012–2022)Emeric Limagne · Université Bourgogne Franche-Comté8 papers (2019–2026)Caroline Truntzer · Research Institute for Genetic and Human Therapy5 papers (2021–2026)Sylvain Ladoire · Université de franche-comté5 papers (2012–2022) · 4 papers (2019–2021)Romain Boidot · Maison des Sciences de l’Homme de Dijon3 papers (2019–2022)Lionel Apetoh · Centre d'Étude des Pathologies Respiratoires3 papers (2019–2022)Frederique Vegran · Centre de recherche Translationnelle en Médecine moléculaire3 papers (2019–2022)Carmen Garrido · Laboratoire de Recherche Vasculaire Translationnelle3 papers (2019–2020)Lionel Apétoh · University of Lausanne2 papers (2012–2017)Philippe Joubert · Université du Québec2 papers (2019–2021)Romain Mary · Centre de recherche Translationnelle en Médecine moléculaire2 papers (2021–2022) · 2 papers (2022–2026) · 2 papers (2022–2026)Vincent Goussot · Université Bourgogne Franche-Comté2 papers (2021–2021)Juliette Albuisson · Genomic and Immunotherapy Medical Institute2 papers (2021–2021)Christophe Hibos · Centre de recherche Translationnelle en Médecine moléculaire2 papers (2021–2022)Bruno Coudert · Centre Georges François Leclerc2 papers (2019–2021)François Ghiringhelli · Peuplements végétaux et bioagresseurs en milieu tropical2 papers (2012–2017)